Value Added Medicines / Scientific, Regulatory and IP Analysis

    2021 TBC, online training

    Summary

    This unique training is focusing on highly evolving areas of Value Added Medicines business development. The participants will explore the scientific, regulatory, intellectual property and clinical challenges of innovative generic portfolio design.

    Who should attend?

    Product portfolio planners, Business development, C-level executives, Heads of R&D, Regulatory affairs, Market access, Mergers and Acquisitions managers, Intellectual property, Pricing & reimbursement

    Learning Objectives

    • The concept of value in the health care environment
    • Analyse the market before embarking on an added value strategy
    • Create viable business models in different markets
    • Is repositioning a high-risk strategy – when could it be suitable for your company?
    • How to differentiate a generic product
    • Select the right route to drug approval
    • What type of products to stay away from because of clinical barriers
    • How to protect your investment through IP

    Key Topics

    • Innovative Generic Business Development
    • A concept of value in health care environment
    • Market Access for Value Added Medicines
    • Drug Repositioning / Repurposing
    • Scientific and Technological solutions for Value Added Medicines
    • Clinical aspects
    • IP and data exclusivity
    • Formulation patents: successes and failures

    Programme

    • All training materials will be provided in digital form
    • All delegates will receive digital and LinkedIn certificates
    • An in-depth scientific discussion of different mechanisms that could lead to an added value product
    • Selecting the right route to drug approval is an essential part of the added value process
    • Case studies of Formulation patents – successes and failures
    • Recent cases regarding Formulation patents and Swiss “use” patents
    • Consequences of market switch from Brand to INN generics

    Trainers

    Generapharm, CEO
    Dr. Ross has over 35 years experience in the Generics Industry, the last 15 being at corporate level. He has been intimately involved in strategic planning, pipeline management and related activities.
    Online Participation
    1 500 Price incl. VAT: 1 500

    Price per delegate including:

    Online participation

    Online workbook & materials

    Certificate

    PC, microphone, camera, stable internet connection and the Zoom application.

    Yes, we will make every effort to ensure best possible interaction. You will see the slides, interact with the trainer and fellow participants. Questions and group exercises will be facilitated through the online meeting platform.

    Yes, you can transfer the registration to a colleague at any time.

    Yes, you may transfer your registration to a different event up to one month before the scheduled dates, provided the training fee has been paid in full.

    Lydia Makori

    l.makori@symmetric.events
    +421 222 200 543